Skip to main content
. 2015 Apr 10;59(5):2583–2587. doi: 10.1128/AAC.05119-14

TABLE 3.

Activities of Debio1452 and comparator antimicrobial agents when tested against 103 isolates of coagulase-negative staphylococcia

Antimicrobial agent used MIC50 (μg/ml) MIC90 (μg/ml) Range (μg/ml) % susceptible/% resistant according tob:
CLSI EUCAST
Debio1452 0.015 0.12 0.004 to 0.5 −/− −/−
Rifampin 0.008 0.015 ≤0.001 to >2 97.1/2.9 −/−
Oxacillin ≤0.25 1 ≤0.25 to >2 83.5/16.5 83.5/16.5
Erythromycin ≤0.25 >2 ≤0.25 to >2 51.5/48.5 51.5/48.5
Clindamycin ≤0.25 >2 ≤0.25 to >2 88.3/11.7 85.4/11.7
Daptomycin 0.25 0.5 ≤0.06 to 1 100.0/− 100.0/0.0
Vancomycin 1 2 0.25 to 2 100.0/0.0 100.0/0.0
Linezolid 0.5 1 ≤0.12 to 1 100.0/0.0 100.0/0.0
Levofloxacin ≤0.5 >4 ≤0.5 to >4 76.7/22.3 76.7/22.3
Tetracycline ≤2 >8 ≤2 to >8 86.3/12.7 82.4/13.7
Trimethoprim-sulfamethoxazole ≤0.5 >2 ≤0.5 to >2 86.4/13.6 86.4/10.7
a

Includes S. epidermidis (56 strains), S. haemolyticus (20 strains), S. hominis (11 strains), S. saprophyticus (6 strains), S. warneri (5 strains), and S. xylosus (5 strains).

b

Susceptibility criteria are as published by the CLSI (14) and EUCAST (15). –, no interpretive criteria exist for this category.